News Inhibrx, Inc.

Equities

INBX

US45720L1070

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
34.32 ^USD	-0.38%		-1.89%	-9.68%

Feb. 28	Inhibrx Shares Fall After Q4 Net Loss Widens	MT
Feb. 28	Earnings Flash (INBX) INHIBRX Reports Q4 Revenue $1.6M	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - HMST, FREE, EVBG, INBX	Mar. 26	PR
Inhibrx Shares Fall After Q4 Net Loss Widens	Feb. 28	MT
Earnings Flash (INBX) INHIBRX Reports Q4 Revenue $1.6M	Feb. 28	MT
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results	Feb. 28	PR
Inhibrx, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Inhibrx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX	Feb. 10	BU
Arecor Therapeutics hails Arestat as 2023 performance "strong"	Feb. 01	AN
Sanofi bets $1.7b on potential best-in-class rare disease therapy	Jan. 24	AQ
Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline	Jan. 24	AQ
North American Morning Briefing : S&P 500 Futures Point to Fresh Record on Netflix Results	Jan. 24	DJ
Health Care Flat After J&J Earnings -- Health Care Roundup	Jan. 23	DJ
Arecor pleased as investee Inhibrx sells therapy to Sanofi	Jan. 23	AN
Sector Update: Health Care Stocks Decline Late Afternoon	Jan. 23	MT
Sector Update: Health Care	Jan. 23	MT
Sanofi Agrees to Buy Inhibrx' Rare Disease Candidate For Up To $2.2 Billion	Jan. 23	MT
Unitholder Alert: Ademi LLP investigates whether Inhibrx, Inc. has obtained a Fair Price in its transaction with Sanofi	Jan. 23	PR
CAC40: slight decline in the absence of catalysts	Jan. 23	CF
CAC40: down in the wake of Bunds and US T-Bonds	Jan. 23	CF
News Highlights : Top Company News of the Day - Tuesday at 11 AM ET	Jan. 23	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Inhibrx, Inc.

Equities

INBX

US45720L1070

Summary

Filters